Juyong Liang

629 total citations
17 papers, 371 citations indexed

About

Juyong Liang is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Juyong Liang has authored 17 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Surgery and 5 papers in Oncology. Recurrent topics in Juyong Liang's work include Thyroid and Parathyroid Surgery (5 papers), Thyroid Cancer Diagnosis and Treatment (4 papers) and RNA modifications and cancer (3 papers). Juyong Liang is often cited by papers focused on Thyroid and Parathyroid Surgery (5 papers), Thyroid Cancer Diagnosis and Treatment (4 papers) and RNA modifications and cancer (3 papers). Juyong Liang collaborates with scholars based in China and United States. Juyong Liang's co-authors include Weihua Qiu, Xi Cheng, Haoran Feng, Zhijian Jin, Jie Kuang, Jiqi Yan, Baiyong Shen, Minmin Shi, Ling Zhan and Xiaonan Shen and has published in prestigious journals such as Oncogene, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

Juyong Liang

17 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Juyong Liang China	10	195	110	88	74	71	17	371
Linfei Hu China	13	268 1.4×	104 0.9×	119 1.4×	68 0.9×	39 0.5×	34	451
Kyo Sasaki Japan	7	119 0.6×	77 0.7×	63 0.7×	47 0.6×	103 1.5×	14	322
Wen‐Lian Chen China	10	262 1.3×	74 0.7×	186 2.1×	50 0.7×	48 0.7×	20	419
Shamini G. Shekeran Singapore	10	174 0.9×	76 0.7×	37 0.4×	60 0.8×	120 1.7×	11	427
Dongdong Zhou China	12	210 1.1×	99 0.9×	146 1.7×	46 0.6×	50 0.7×	29	389
Jingtai Zhi China	13	231 1.2×	102 0.9×	77 0.9×	68 0.9×	34 0.5×	29	443
Hamza Chettouh France	6	233 1.2×	82 0.7×	112 1.3×	53 0.7×	90 1.3×	7	421
Ailing Zhong China	13	192 1.0×	124 1.1×	104 1.2×	59 0.8×	23 0.3×	29	355
Mingbo Cao China	7	205 1.1×	140 1.3×	104 1.2×	140 1.9×	51 0.7×	14	430
Liqiong Xue China	12	147 0.8×	147 1.3×	51 0.6×	60 0.8×	28 0.4×	33	411

Countries citing papers authored by Juyong Liang

Since Specialization

Citations

This map shows the geographic impact of Juyong Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juyong Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juyong Liang more than expected).

Fields of papers citing papers by Juyong Liang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juyong Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juyong Liang. The network helps show where Juyong Liang may publish in the future.

Co-authorship network of co-authors of Juyong Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Juyong Liang. A scholar is included among the top collaborators of Juyong Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juyong Liang. Juyong Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Liang, Juyong, et al.. (2025). The endoplasmic reticulum stress-ferroptosis reciprocal signaling orchestrates anti-tumor effect of anlotinib in anaplastic thyroid cancer. Cancer Cell International. 25(1). 310–310. 1 indexed citations

Liang, Juyong, et al.. (2024). Parathyroidectomy for solitary parathyroid adenoma via trans‐areola single site endoscopic approach: Results of a case‐match study. Cancer Medicine. 13(10). e7290–e7290. 1 indexed citations

Li, Shilin, Pei Du, Yining Zhang, et al.. (2024). Quantitative comparison of three thyroidectomy approaches in neck muscles, voice, and swallowing functions. Asian Journal of Surgery. 47(4). 1734–1739. 1 indexed citations

Liang, Juyong, Ruiqi Liu, Liehao Jiang, et al.. (2023). Autophagic blockade potentiates anlotinib-mediated ferroptosis in anaplastic thyroid cancer. Endocrine Related Cancer. 30(9). 19 indexed citations

Xuan, Ming, Juyong Liang, Zheyu Yang, et al.. (2023). Learning curve of trans‐areola single‐site endoscopic thyroidectomy in a high‐volume center: A CUSUM‐based assessment. Cancer Medicine. 12(16). 16846–16858. 7 indexed citations

Feng, Haoran, Zheyu Yang, Juyong Liang, et al.. (2022). The central role of a two‐way positive feedback pathway in molecular targeted therapies‐mediated pyroptosis in anaplastic thyroid cancer. Clinical and Translational Medicine. 12(2). e727–e727. 35 indexed citations

Luo, Jing, Jianbo Li, Juyong Liang, et al.. (2022). Genomics, Origin and Selection Signals of Loudi Cattle in Central Hunan. Biology. 11(12). 1775–1775. 4 indexed citations

Feng, Haoran, Zhijian Jin, Juyong Liang, et al.. (2021). FOXK2 transcriptionally activating VEGFA induces apatinib resistance in anaplastic thyroid cancer through VEGFA/VEGFR1 pathway. Oncogene. 40(42). 6115–6129. 21 indexed citations

Liang, Juyong, Zhijian Jin, Jie Kuang, et al.. (2021). The role of anlotinib-mediated EGFR blockade in a positive feedback loop of CXCL11-EGF-EGFR signalling in anaplastic thyroid cancer angiogenesis. British Journal of Cancer. 125(3). 390–401. 28 indexed citations

10.

Liang, Juyong, Ling Zhan, Ming Xuan, et al.. (2021). Thyroidectomy for thyroid cancer via transareola single-site endoscopic approach: results of a case-match study with large-scale population. Surgical Endoscopy. 36(2). 1394–1406. 9 indexed citations

11.

Feng, Haoran, Xiaonan Shen, Juyong Liang, et al.. (2020). Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5+ colorectal cancer. Cell Death and Disease. 11(10). 1006–1006. 40 indexed citations

12.

Feng, Haoran, Kun Liu, Xiaonan Shen, et al.. (2020). Correction: Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5+ colorectal cancer. Cell Death and Disease. 11(11). 4 indexed citations

13.

Jin, Zhijian, Haoran Feng, Juyong Liang, et al.. (2020). FGFR3△7–9 promotes tumor progression via the phosphorylation and destabilization of ten-eleven translocation-2 in human hepatocellular carcinoma. Cell Death and Disease. 11(10). 903–903. 18 indexed citations

14.

Cheng, Xi, Zhijian Jin, Xiaopin Ji, et al.. (2019). ETS variant 5 promotes colorectal cancer angiogenesis by targeting platelet‐derived growth factor BB. International Journal of Cancer. 145(1). 179–191. 30 indexed citations

15.

Cheng, Xi, Jie Kuang, Haoran Feng, et al.. (2018). CQ sensitizes human pancreatic cancer cells to gemcitabine through the lysosomal apoptotic pathway via reactive oxygen species. Molecular Oncology. 12(4). 529–544. 38 indexed citations

16.

Cheng, Xi, Haoran Feng, Zhijian Jin, et al.. (2018). Intraoperative carbon nanoparticles mapping in secondary total thyroidectomy for recurrent thyroid nodules: Results of a 8-criterion case-match study (case control study). International Journal of Surgery. 60. 210–215. 5 indexed citations

17.

Feng, Haoran, Xi Cheng, Jie Kuang, et al.. (2018). Apatinib-induced protective autophagy and apoptosis through the AKT–mTOR pathway in anaplastic thyroid cancer. Cell Death and Disease. 9(10). 1030–1030. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact